Literature DB >> 27144098

Effects of high glucose on caveolin-1 and insulin signaling in 3T3-L1 adipocytes.

Sara Palacios-Ortega1, Maider Varela-Guruceaga1, J Alfredo Martínez2, Carlos de Miguel3, Fermín I Milagro2.   

Abstract

Adipocytes exposed to high glucose concentrations exhibit impaired metabolic function, including an increase of oxidative and proinflammatory factors that might favor the development of insulin resistance. Caveolin-1 (Cav-1) is a key mediator of the insulin transduction pathway whose expression is significantly enhanced during adipocyte differentiation. In this work, we studied the effects of high glucose concentration on the regulation of Cav-1 expression and activation and its relation to the insulin signaling pathway during the adipogenic process and in long-term differentiated adipocytes. Both, long-term high glucose exposure during adipogenesis and short-term glucose incubation of mature adipocytes, promoted triglyceride accumulation in 3T3-L1 cells. The short-term exposure of mature adipocytes to high glucose significantly reduced the sensitivity to insulin of Cav-1, insulin receptor (IR) and potein kinase B (AKT-2) phosphorylation, as well as insulin-induced deoxyglucose uptake. Adipocytes differentiated in the presence of high glucose lost Cav-1 and IR response to insulin-stimulated phosphorylation, but maintained the insulin sensitivity of AKT-2 phosphorylation and deoxyglucose uptake. Although long-term high glucose exposure increased DNA methylation in Cav-1 promoter, Cav-1 expression was not affected. Moreover, these cells showed an increase of Cav-1, IR and AKT-2 protein content, pointing to an adaptive response induced by the long-term high glucose exposure.

Entities:  

Keywords:  3T3-L1; DNA methylation; GLUT4; adipogenesis; glucose uptake; insulin receptor; leptin

Year:  2015        PMID: 27144098      PMCID: PMC4836491          DOI: 10.1080/21623945.2015.1122856

Source DB:  PubMed          Journal:  Adipocyte        ISSN: 2162-3945            Impact factor:   4.534


  57 in total

1.  Reduced glucose uptake precedes insulin signaling defects in adipocytes from heterozygous GLUT4 knockout mice.

Authors:  J Li; K L Houseknecht; A E Stenbit; E B Katz; M J Charron
Journal:  FASEB J       Date:  2000-06       Impact factor: 5.191

Review 2.  Proinflammatory effects of glucose and anti-inflammatory effect of insulin: relevance to cardiovascular disease.

Authors:  Paresh Dandona; Ajay Chaudhuri; Husam Ghanim; Priya Mohanty
Journal:  Am J Cardiol       Date:  2006-12-27       Impact factor: 2.778

Review 3.  A second protein marker of caveolae: caveolin-2.

Authors:  Liu-luan Zhu; Ying Cui; Yong-sheng Chang; Fu-de Fang
Journal:  Chin Med Sci J       Date:  2010-06

4.  The insulin receptor catalyzes the tyrosine phosphorylation of caveolin-1.

Authors:  Akiko Kimura; Silvia Mora; Satoshi Shigematsu; Jeffrey E Pessin; Alan R Saltiel
Journal:  J Biol Chem       Date:  2002-05-29       Impact factor: 5.157

Review 5.  Oxidative stress, insulin signaling, and diabetes.

Authors:  Justin L Rains; Sushil K Jain
Journal:  Free Radic Biol Med       Date:  2010-12-13       Impact factor: 7.376

Review 6.  Adipokines in inflammation and metabolic disease.

Authors:  Noriyuki Ouchi; Jennifer L Parker; Jesse J Lugus; Kenneth Walsh
Journal:  Nat Rev Immunol       Date:  2011-01-21       Impact factor: 53.106

7.  Low plasma leptin levels contribute to diabetic hyperphagia in rats.

Authors:  D K Sindelar; P J Havel; R J Seeley; C W Wilkinson; S C Woods; M W Schwartz
Journal:  Diabetes       Date:  1999-06       Impact factor: 9.461

8.  The effect of glucose concentration on insulin-induced 3T3-L1 adipose cell differentiation.

Authors:  A Gagnon; A Sorisky
Journal:  Obes Res       Date:  1998-03

9.  The effect of hyperglycemia and hypoglycemia on glucose transport and expression of glucose transporters in human lymphocytes B and T: an in vitro study.

Authors:  Bożenna Oleszczak; Leszek Szablewski; Monika Pliszka
Journal:  Diabetes Res Clin Pract       Date:  2012-01-16       Impact factor: 5.602

10.  Folic acid supplementation during the juvenile-pubertal period in rats modifies the phenotype and epigenotype induced by prenatal nutrition.

Authors:  Graham C Burdge; Karen A Lillycrop; Emma S Phillips; Joanne L Slater-Jefferies; Alan A Jackson; Mark A Hanson
Journal:  J Nutr       Date:  2009-04-01       Impact factor: 4.798

View more
  7 in total

1.  Effects of exosomes from LPS-activated macrophages on adipocyte gene expression, differentiation, and insulin-dependent glucose uptake.

Authors:  Nicolás De Silva; Mirian Samblas; J Alfredo Martínez; Fermín I Milagro
Journal:  J Physiol Biochem       Date:  2018-03-20       Impact factor: 4.158

Review 2.  Signaling pathways in obesity: mechanisms and therapeutic interventions.

Authors:  Xue Wen; Bohan Zhang; Beiyi Wu; Haitao Xiao; Zehua Li; Ruoyu Li; Xuewen Xu; Tao Li
Journal:  Signal Transduct Target Ther       Date:  2022-08-28

Review 3.  Milk's Role as an Epigenetic Regulator in Health and Disease.

Authors:  Bodo C Melnik; Gerd Schmitz
Journal:  Diseases       Date:  2017-03-15

Review 4.  Insulin Receptor Trafficking: Consequences for Insulin Sensitivity and Diabetes.

Authors:  Yang Chen; Lili Huang; Xinzhou Qi; Chen Chen
Journal:  Int J Mol Sci       Date:  2019-10-10       Impact factor: 5.923

5.  Caveolin-1 Regulation and Function in Mouse Uterus during Early Pregnancy and under Human In Vitro Decidualization.

Authors:  Zhuo Song; Bo Li; Mengyuan Li; Jiamei Luo; Yuqi Hong; Yuying He; Siting Chen; Zhenshan Yang; Chen Liang; Zengming Yang
Journal:  Int J Mol Sci       Date:  2022-03-28       Impact factor: 5.923

Review 6.  Role of Caveolin-1 in Diabetes and Its Complications.

Authors:  Dania Haddad; Ashraf Al Madhoun; Rasheeba Nizam; Fahd Al-Mulla
Journal:  Oxid Med Cell Longev       Date:  2020-01-27       Impact factor: 6.543

Review 7.  Caveolin-1 Regulates Cellular Metabolism: A Potential Therapeutic Target in Kidney Disease.

Authors:  Shilu Luo; Ming Yang; Hao Zhao; Yachun Han; Na Jiang; Jinfei Yang; Wei Chen; Chenrui Li; Yan Liu; Chanyue Zhao; Lin Sun
Journal:  Front Pharmacol       Date:  2021-12-10       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.